Key facts
- This page summarizes Todd S. Thomson's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
- 4 reported transactions and 28 derivative rows are listed below.
- Accepted by SEC: 02 Nov 2026, 16:27.
Todd S. Thomson - 28 Oct 2026 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)
- Reporting relationship
- Director
- Issuer ticker
- ACTU
- Reported as of
- 28 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Nov 2026, 16:27:12 UTC
- Prior SEC filing
- 22 May 2026
- Source filing
- View source filing
- Reporting owner signature
- TODD THOMSON, Name: /s/ Todd Thomson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Todd S. Thomson filed Form 4 for ACTUATE THERAPEUTICS, INC. (ACTU) on 02 Nov 2026.
Change
- Previous filing in this sequence was filed on 22 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (7)
CIK 0001225707
Primary reporting owner
THOMSON TODD S
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- TODD THOMSON, Name: /s/ Todd Thomson
- Signature date
- 02 Nov 2026
CIK 0001696711
Kairos Venture Partners II, L.P.
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- KAIROS VENTURE PARTNERS II, L.P., Name: /s/ James T Demetriades, Title: Authorized Signatory
- Signature date
- 02 Nov 2026
CIK 0001772438
Kairos Venture Opportunities I, L.P.
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- KAIROS VENTURE OPPORTUNITIES I, LP, Name: /s/ James T Demetriades, Title: Authorized Signatory
- Signature date
- 02 Nov 2026
CIK 0001788046
Kairos SPV Fund LLC
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- KAIROS SPV FUND, LLC, Name: /s/ James T Demetriades, Title: Authorized Signatory
- Signature date
- 02 Nov 2026
CIK 0001835962
Kairos-Actuate SPV, L.P.
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- KAIROS-ACTUATE SPV, L.P., Name: /s/ James T Demetriades, Title: Authorized Signatory
- Signature date
- 02 Nov 2026
CIK 0002111572
Kairos Venture Investments, LLC
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- KAIROS VENTURE INVESTMENT, LLC, Name: /s/ James T Demetriades, Title: Authorized Signatory
- Signature date
- 02 Nov 2026
CIK 0001134387
DEMETRIADES JAMES T
- Relationship
- Director
- Address
- 9440 S. SANTA MONICA BLVD, SUITE # 710, BEVERLY HILLS
- Signature
- JAMES DEMETRIADES, Name: /s/ James Demetriades
- Signature date
- 02 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +269,017
- Change %
- Price
- Shares after
- 269,017
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Partners II, LP
- Underlying class
- Common Stock
- Underlying amount
- 269,017
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +259,572
- Change %
- Price
- Shares after
- 259,572
- Date
- 28 Oct 2026
- Ownership
- By Kairos Venture Opportunities I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 259,572
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +75,738
- Change %
- Price
- Shares after
- 75,738
- Date
- 28 Oct 2026
- Ownership
- By Kairos-Actuate SPV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 75,738
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
ACTU
transaction
Derivative
Warrants (right to buy)
Award
- Transaction value
- Shares
- +95,673
- Change %
- Price
- Shares after
- 95,673
- Date
- 28 Oct 2026
- Ownership
- By Kairos SPV Fund, LLC
- Underlying class
- Common Stock
- Underlying amount
- 95,673
- Exercise price
- $0.5325
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The securities of Actuate Therapeutics, Inc. ("Actuate") that are reported herein are held directly by Kairos-Actuate SPV, L.P., Kairos Venture Partners II, L.P., Kairos Venture Opportunities I, L.P., and Kairos SPV Fund, LLC (collectively, the "Kairos Funds"). The Kairos Funds are managed and controlled by Kairos Venture Investments, LLC ("KVI"), subject to the Limited Partnership Agreements in place for each Kairos Fund. Todd Thomson serves as Chief Financial Officer/Chief Operating Officer of KVI and is a director on the board of directors of Actuate. James Demetriades is the Chief Executive Officer of KVI.
Footnote F2
Each of KVI, Mr. Thomson and Mr. Demetriades may be deemed to indirectly beneficially own the securities of Actuate held directly by the Kairos Funds. Each of KVI, Mr. Thomson and Mr. Demetriades disclaims beneficial ownership of the securities of Actuate held directly by the Kairos Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of KVI, Mr. Thomson or Mr. Demetriades is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Footnote F3
In consideration for an agreement between Actuate and the Kairos Funds pursuant to which the Kairos Funds agreed, subject to certain limited exceptions, not to sell, transfer or dispose of, directly or indirectly, any shares of Actuate's common stock beneficially owned by them or any securities convertible into or exercisable or exchangeable for shares of Actuate's common stock for a period of two years from the close of Actuate's public offering of shares of common stock (the "Offering") on October 28, 2026, Actuate agreed to issue warrants to purchase 700,000 shares of Actuate's common stock in the aggregate (the "Warrants") to the Kairos Funds in the amounts reported herein subject to the closing of the Offering.
Footnote F4
The Warrants were immediately exercisable upon issuance and expire five years after the closing of the Offering.
SEC remarks
Todd Thomson serves as CFO/COO of Kairos Venture Investments, LLC and is a director on the board of directors of Actuate Therapeutics, Inc. ("Actuate"). Due to their relationship with Todd Thomson, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the Reporting Persons other than Todd Thomson are deemed to be directors by deputization of Actuate.